126 related articles for article (PubMed ID: 23212324)
1. Lack of an association between the XRCC1 Arg399Gln polymorphism and gastric cancer based on a meta-analysis.
Liu BM; Liu TM; You BS; You HY; Yang J; Li L; He YC
Genet Mol Res; 2012 Nov; 11(4):3852-60. PubMed ID: 23212324
[TBL] [Abstract][Full Text] [Related]
2. Association between the XRCC1 Arg399Gln polymorphism and risk of cervical carcinoma: a meta-analysis.
Liu DY; Liang HC; Xiao XM
Genet Mol Res; 2015 Aug; 14(3):9821-8. PubMed ID: 26345915
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis demonstrates no association between XRCC1 Arg399Gln polymorphism and bladder cancer risk.
Dong LM; Zhang XY; Teng H; Li MS; Wang P
Genet Mol Res; 2014 Nov; 13(4):9976-85. PubMed ID: 25501209
[TBL] [Abstract][Full Text] [Related]
4. Association of XRCC1 Arg399Gln polymorphism with bladder cancer susceptibility: a meta-analysis.
Yang D; Liu C; Shi J; Wang N; Du X; Yin Q; Wang Y
Gene; 2014 Jan; 534(1):17-23. PubMed ID: 24176953
[TBL] [Abstract][Full Text] [Related]
5. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
[TBL] [Abstract][Full Text] [Related]
6. Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis.
Peng M; Zhou X; Ding X; Wei L; Zhao Y; Zhu T; Shi X; Qin D
Rheumatol Int; 2017 Mar; 37(3):435-444. PubMed ID: 27812739
[TBL] [Abstract][Full Text] [Related]
7. XRCC1 Arg399Gln polymorphism and bladder cancer risk: updated meta-analyses based on 5767 cases and 6919 controls.
Zhuo W; Zhang L; Cai L; Zhu B; Chen Z
Exp Biol Med (Maywood); 2013 Jan; 238(1):66-76. PubMed ID: 23479765
[TBL] [Abstract][Full Text] [Related]
8. XRCC1 Arg399Gln, Arg194Trp and Arg280His polymorphisms in breast cancer risk: a meta-analysis.
Huang Y; Li L; Yu L
Mutagenesis; 2009 Jul; 24(4):331-9. PubMed ID: 19465687
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis demonstrates lack of association of the hOGG1 Ser326Cys polymorphism with bladder cancer risk.
Zhong DY; Chu HY; Wang ML; Ma L; Shi DN; Zhang ZD
Genet Mol Res; 2012 Sep; 11(3):3490-6. PubMed ID: 23079842
[TBL] [Abstract][Full Text] [Related]
10. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of the association between the XRCC1 gene R399Q polymorphism and colorectal cancer: an update.
Wu W; Wu Y; Wang M; Zhang D
Int J Colorectal Dis; 2013 Oct; 28(10):1453-4. PubMed ID: 23233244
[No Abstract] [Full Text] [Related]
12. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures.
Saadat M; Ansari-Lari M
Breast Cancer Res Treat; 2009 May; 115(1):137-44. PubMed ID: 18481169
[TBL] [Abstract][Full Text] [Related]
13. The Association Between the XRCC1 Arg399Gln Polymorphism and the Risk of Head and Neck Cancer: An Updated Meta-Analysis Including 14586 Subjects.
Xia S; Wu S; Wang M
Technol Cancer Res Treat; 2021; 20():15330338211033060. PubMed ID: 34278875
[TBL] [Abstract][Full Text] [Related]
14. Association between the XRCC1 Arg399Gln polymorphism and head and neck cancer susceptibility: a meta-analysis based on case-control studies.
Liu C; Yin Q; Jiao G; Zhou X; Ying M; Gao W; Hu J; Wei L; Wang N; Wang Y
DNA Cell Biol; 2014 Jun; 33(6):378-87. PubMed ID: 24694255
[TBL] [Abstract][Full Text] [Related]
15. Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: a meta-analysis.
Yuan H; Niu YM; Wang RX; Li HZ; Chen N
Genet Mol Res; 2011 Nov; 10(4):3356-64. PubMed ID: 22179996
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in DNA repair gene XRCC1 and skin cancer risk: a meta-analysis.
Zhang H; Li W; Franklin MJ; Dudek AZ
Anticancer Res; 2011 Nov; 31(11):3945-52. PubMed ID: 22110224
[TBL] [Abstract][Full Text] [Related]
17. Lack of an association between TSC gene Arg904Gln polymorphisms and essential hypertension risk based on a meta-analysis.
Zhang F; Yang Y; Hu D; Lei H; Wang Y
Genet Mol Res; 2012 Sep; 11(3):3511-7. PubMed ID: 23079845
[TBL] [Abstract][Full Text] [Related]
18. XRCC1 Arg399Gln gene polymorphism and breast cancer risk: a meta-analysis based on case-control studies.
Wu K; Su D; Lin K; Luo J; Au WW
Asian Pac J Cancer Prev; 2011; 12(9):2237-43. PubMed ID: 22296363
[TBL] [Abstract][Full Text] [Related]
19. Association of a tgf-b1-509c/t polymorphism with gastric cancer risk: a meta-analysis.
Li K; Xia F; Zhang K; Mo A; Liu L
Ann Hum Genet; 2013 Jan; 77(1):1-8. PubMed ID: 23088218
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer.
Brewster AM; Jorgensen TJ; Ruczinski I; Huang HY; Hoffman S; Thuita L; Newschaffer C; Lunn RM; Bell D; Helzlsouer KJ
Breast Cancer Res Treat; 2006 Jan; 95(1):73-80. PubMed ID: 16319991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
